Alessia Riccio

Alessia Riccio

Auto-generated profile, based on publicly available information

Alessia Riccio

Department of Clinical and Molecular Medicine, University of Rome-Sapienza, 00189, Rome, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2024 in European Journal of Internal Medicine
Verified
Journal Article
Open access
CCChiara Maria Assunta Cefalo
Chiara Maria Assunta Cefalo
ARAlessia Riccio
Alessia Riccio
TFTeresa Vanessa Fiorentino
Teresa Vanessa Fiorentino
Elena SuccurroElena Succurro
Elena Succurro
MPMaria Perticone
Maria Perticone
GSGiorgio Sesti
Giorgio Sesti
Impaired myocardial mechano-energetic efficiency (MEE) has been associated with cardiac insulin resistance measured by dynamic positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) combined with euglycemic-hyperinsulinemic clamp. Estimate glucose disposal rate (eGDR) index has a good correlation with whole-body insulin sensitivity. It remains unsettled whether eGDR index is a suitable proxy of cardiac insulin sensitivity as well as its association with myocardial MEE. The aims of this study were: 1) to compare eGDR index with HOMA-IR, QUICKI and FIRI indexes for association with myocardial glucose metabolic rate (MrGlu); and 2) to determine the association of eGDR index with myocardial MEE. We evaluated MrGlu using PET with 18F-FDG combined with euglycemic-hyperinsulinemic clamp in 50 individuals without history of coronary heart disease. Myocardial MEE per gram of left ventricular mass (MEEi) was measured in 1181 subjects by echocardiography. eGDR (mg kg-1/min) was calculated as: 21.158 - (0.09 × waist circumference in cm) - (3.407 × hypertension, 1 = yes 0 = no) - (0.551 × HbA1c%). eGDR index was more strongly associated with myocardial MrGlu than HOMA-IR, QUICKI, and FIRI indexes (r = -0.662, r = -0.492, r = 0.570, and r = -0.492, respectively). Individuals in the lower tertiles of eGDR exhibited a significant reduction of MEEi as compared to those in the highest tertile (P < 0.001). In a stepwise multivariate linear regression analysis eGDR index was the major determinant of MEEi independently of well-established cardio-metabolic risk factors. These data suggest that the eGDR index may be a useful marker to identifying individuals at high cardiovascular risk.

21 January 2024 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
CCChiara Maria Assunta Cefalo
Chiara Maria Assunta Cefalo
ARAlessia Riccio
Alessia Riccio
TFTeresa Vanessa Fiorentino
Teresa Vanessa Fiorentino
MMMattia Massimino
Mattia Massimino
GMGaia Chiara Mannino
Gaia Chiara Mannino
GSGiorgio Sesti
Giorgio Sesti

22 March 2023 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
ARAlessia Riccio
Alessia Riccio
CMCamilla Mazzanti
Camilla Mazzanti
LVLaura Vero
Laura Vero
TFTeresa Vanessa Fiorentino
Teresa Vanessa Fiorentino
Elena SuccurroElena Succurro
Elena Succurro
GSGiorgio Sesti
Giorgio Sesti
Decreased myocardial mechano-energetic efficiency (MEEi) is associated with NAFLD and poorer prognosis in liver cirrhosis. We aim to investigate the association between liver fibrosis severity and MEEi in individuals participating in the CATAnzaro MEtabolic RIsk factors (CATAMERI) study. Myocardial MEEi, assessed by an echocardiography-derived measure, and fibrosis severity, estimated by the fibrosis-4 index (FIB-4), were evaluated in 2383 subjects with different degree of glucose tolerance. Participants were divided into four groups according to FIB-4 index values: lowest risk of fibrosis (<1.3); low risk of fibrosis (≥1.3 to < 1.67); moderate risk of fibrosis (≥1.67 to < 2.67); high risk of fibrosis (≥2.67). Subjects with higher risk of liver fibrosis displayed a graded decrease in myocardial MEEi compare to those with the lowest risk of liver fibrosis. In a multivariable regression analysis, FIB-4 index was independently associated with MEEi (β = -0.080, P < 0.001), along with total cholesterol (β = -0.067, P = 0.01), hsCRP (β = -0.081, P < 0.001), sex (β = -0.099, P < 0.001), glucose tolerance status (β = -0.109, <0.001) and HOMA-IR index (β = -0.143, P < 0.001). Compromised myocardial MEEi is already reported in individuals with high risk of hepatic fibrosis suggesting that its assessment may help to identify among subjects with NAFLD those with worst prognosis.